AstraZeneca and Sinovac COVID-19 shots get emergency nod in Brazil
Astrazeneca expectations
For this year Astrazeneca 's revenue will be around 26.34 billion GBp. This is according to the average of the analysts' estimates. This is slightly more than 2019's revenue of 24.38 billion GBp.
Historical revenues and results Astrazeneca plus estimates 2020
Astrazeneca The analysts expect for 2020 a net profit of 5.32 billion GBp. According to most of the analysts the company will have a profit per share for this book year of 405 GBp. So the price/earnings-ratio equals 19.07.
Huge dividend Astrazeneca
Per share the analysts expect a dividend of 281 GBp per share. The dividend yield is then 3.64 percent. The average dividend yield of the pharmaceutical companies equals a poor 0.16 percent.Newest target prices around 8965 GBp
The latest 3 recommendations for the pharmaceutical company were provided by Liberum, ABN AMRO and Jefferies & Co..Astrazeneca 's market capitalization is based on the number of outstanding shares around 9784.08 billion GBp. The Astrazeneca stock was the past 12 months quite volatile. Since last January the stock is 1 percent higher. This year the stock price moved between 5871 and 10120 GBp.
Historical stock prices Astrazeneca
Click here for dividend Astrazeneca. At 18.00 the stock trades 0.78 percent higher at 7722 GBp.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
